CD8A and gastric cancer: (134) demonstrated that Modified Buzhong Yiqi Tang significantly prolonged the survival of mice bearing gastric cancer, increased the CD4+/CD8+ ratio in the observation group, and decreased the ratio of CD8+ PD-1 T cells and Treg PD-1 cells.